Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis
Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study
Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Xarelto Side Effects Linked to Reports of Problems, Deaths: Report September 10, 2013 Irvin Jackson Add Your Comments A new report suggests that side effects of Xarelto, which is a relatively new anticoagulant that is part of the same class of medications as the controversial drug Pradaxa, may be responsible for dozens of patient deaths and hundreds of adverse event reports. The German newspaper Der Speigel (in German) indicates that at least 968 adverse events involving Xarelto were reported to German health officials in the first eight months of 2013, including 72 deaths. The numbers compare to 750 adverse event reports and 58 deaths throughout all of last year, indicating that the the increase tracks with the rise in use of Xarelto, which has reportedly increased 240% after just a year and a half on the market. Learn More About Pradaxa Internal Bleeding Lawsuit Side effects of Pradaxa may increase risk of severe bleeding and death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Pradaxa Internal Bleeding Lawsuit Side effects of Pradaxa may increase risk of severe bleeding and death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Xarelto (rivaroxaban) is one of a new generation of anticoagulants used to reduce the risk of blood clots and strokes. Known as “direct thrombin inhibitors,” the new class of medications are marketed as a replacement for Coumadin, or warfarin, which has long been the standard anticoagulation therapy. The new class of treatments have been promoted as superior to warfarin because they are easier to take and require less frequent monitoring to maintain the correct dose. Pradaxa (dabigatran) is another medication in the same class, and has become the most widely used after Boehringer Ingelheim was able to gain the market advantage of being the first to market. However, as adoption of these new anticoagulants increases, concerns have surfaced about the risk of serious and potentially life-threatening problems, including the risk of uncontrollable bleeding from Pradaxa and Xarelto. While all blood thinners carry a risk of bleeding, Xarelto, Pradaxa and other direct thrombin inhibitors currently lack an effective reversal agent. While doctors are able to administer a dose of vitamin K and plasma to reverse any bleeding problems that develop with warfarin, no such antidote is available for the new class of medication, making it harder to prevent serious injury or death if patients suffer bleeding problems. Concerns about the safety of Pradaxa began to surface shortly after the medication was introduced in October 2010, as it quickly became one of the drugs most commonly associated with adverse event reports submitted to the FDA. During 2011, the first full year the drug was on the market, the Institute for Safe Medication Practices (ISMP) found that adverse event reports involving Pradaxa problems surpassed all other medications regularly monitored by the group. The FDA received at least 3,781 reports involving serious injuries associated with the use of Pradaxa during 2011, including 2,367 reports of hemorrhage and 542 patient deaths. Boehringer Ingelheim currently faces hundreds of Pradaxa bleeding lawsuits that have been filed on behalf of former users of the medication who allege that the drug maker failed to adequately warn about the risk uncontrollable bleeding or the lack of an available reversal agent to stop bleeding problems that may develop. Bayer and Johnson & Johnson are working with a company called Portola Pharmaceuticals to try and develop a Xarelto reversal agent and are testing one possible antidote. Boehringer Ingelheim is also reportedly looking for a reversal agent for Pradaxa. Officials at Bayer say that despite the growing adverse event reports, the benefits of Xarelto outweigh the risks and they and Johnson & Johnson are trying to spread the drug to even more patients by investigating its potential use to treat patients suffering from heart failure and coronary artery disease. The drug generated $425 million in sales last year and has nearly reached the half billion mark already this year. Tags: Bayer, Bleeding, Blood Thinners, Boehringer Ingelheim, Coumadin, Johnson & Johnson, Pradaxa, Warfarin, Xarelto Image Credit: | More Pradaxa Lawsuit Stories Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis November 21, 2024 Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study September 1, 2022 Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study October 15, 2021 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Alleges Intracranial Meningioma From Depo-Provera Resulted in Need for Lifelong Medical Monitoring (Posted: yesterday) A Depo-Provera lawsuit claims a woman will need medical monitoring for the rest of her life, after developing an intracranial meningioma caused by the use of the birth control shot. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Sign Ups Expected To Continue as First Brain Tumor Cases Prepared for Trial (05/23/2025)Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (05/15/2025)Depo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025) Court Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (Posted: yesterday) Following the first federal bellwether trial expected to begin in September 2025, a group of four additional Valsartan lawsuits will be prepared for a second wave of trials. MORE ABOUT: VALSARTAN LAWSUITOrder Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)Parties Propose Schedules for Second Wave of Valsartan Bellwether Lawsuits (02/20/2025) AFFF Kidney Cancer Lawsuits Proposed For Oct. 20, 2025 Bellwether Trial Date (Posted: 2 days ago) Plaintiffs lawyers have outlined the order in which they believe three AFFF lawsuits should go to trial, indicating that each involves an individual diagnosed with kidney cancer after drinking from the same contaminated water source in Pennsylvania. MORE ABOUT: AFFF LAWSUIT3M PFAS Water Contamination Settlement Results in $450M Payout to New Jersey (05/14/2025)Court Urged To Combine 5 AFFF Lawsuits For First MDL Bellwether Trial (05/08/2025)Additional AFFF Ulcerative Colitis Lawsuits Added to Bellwether Discovery Pool (04/29/2025)
Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis November 21, 2024
Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study September 1, 2022
Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study October 15, 2021
Lawsuit Alleges Intracranial Meningioma From Depo-Provera Resulted in Need for Lifelong Medical Monitoring (Posted: yesterday) A Depo-Provera lawsuit claims a woman will need medical monitoring for the rest of her life, after developing an intracranial meningioma caused by the use of the birth control shot. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Sign Ups Expected To Continue as First Brain Tumor Cases Prepared for Trial (05/23/2025)Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (05/15/2025)Depo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)
Court Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (Posted: yesterday) Following the first federal bellwether trial expected to begin in September 2025, a group of four additional Valsartan lawsuits will be prepared for a second wave of trials. MORE ABOUT: VALSARTAN LAWSUITOrder Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)Parties Propose Schedules for Second Wave of Valsartan Bellwether Lawsuits (02/20/2025)
AFFF Kidney Cancer Lawsuits Proposed For Oct. 20, 2025 Bellwether Trial Date (Posted: 2 days ago) Plaintiffs lawyers have outlined the order in which they believe three AFFF lawsuits should go to trial, indicating that each involves an individual diagnosed with kidney cancer after drinking from the same contaminated water source in Pennsylvania. MORE ABOUT: AFFF LAWSUIT3M PFAS Water Contamination Settlement Results in $450M Payout to New Jersey (05/14/2025)Court Urged To Combine 5 AFFF Lawsuits For First MDL Bellwether Trial (05/08/2025)Additional AFFF Ulcerative Colitis Lawsuits Added to Bellwether Discovery Pool (04/29/2025)